Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-04

Clinical Trial Update: Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating when to restart direct oral anticoagulants after traumatic intracranial hemorrhage. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DOACs (direct oral anticoagulants) (direct oral anticoagulants)

Snippet

Sponsor: Walton Centre NHS Foundation Trust | Conditions: Traumatic Intracranial Haemorrhage | Phase 3 | Status: RECRUITING